My LDL Looks Fine. Could ApoB Tell a Different Story?
LDL-C shows how much cholesterol is being carried. ApoB helps estimate how many plaque-forming particles are carrying it. Sometimes the two results tell a different story.
Dear reader,
Here is the question that changed this Letter:
My LDL looks reasonable. Could ApoB tell a different story?
I asked Allan D. Sniderman, MD, Edwards Professor of Cardiology and Professor of Medicine at McGill University, to review the book's brief section on cholesterol and ApoB. He did not agree completely with what I had written. I went back to the evidence and made the explanation clearer.
The useful question is not whether everyone needs another test. It is whether ApoB would add information that could change how your own cholesterol story is understood.
The short answer
Sometimes. ApoB can show something a standard cholesterol result may miss.
LDL-C tells you how much cholesterol is being carried in certain particles. ApoB helps estimate how many plaque-forming particles are carrying it. Two women can have similar LDL-C results but different particle numbers.
When the two results tell different stories, ApoB may change how a clinician understands cholesterol-related risk or approaches a prevention conversation. ApoB cannot show whether plaque is already present, explain a symptom, or decide treatment by itself.
The heart explanation
LDL-C shows the cargo. ApoB shows the traffic.
Think of cholesterol as cargo and the particles carrying it as cars. The same amount of cargo can travel in fewer cars or many more cars. LDL-C helps describe the cargo. ApoB helps estimate the traffic.
Each of these plaque-forming particles carries one ApoB molecule, so an ApoB result gives a practical estimate of how many are circulating. More particles mean more opportunities for one to enter the artery wall over time.
Do not blend the tests
Different question. Different answer.
LDL-C
The amount of cholesterol carried inside LDL particles.What it helps answerHow much LDL cholesterol is circulating?
What it cannot answer aloneHow many plaque-forming particles are carrying that cholesterol.
ApoB
An estimate of how many plaque-forming particles are circulating.What it helps answerCould the number of particles be higher than my LDL-C suggests?
What it cannot answer aloneWhether plaque is already present or whether treatment is right for you.
Lp(a)
A separate blood test for a heart-risk clue that comes mostly from your genes.What it helps answerCould a high Lp(a) level I inherited raise my chance of heart disease?
Ask your clinicianIf my Lp(a) is elevated, should my parents, siblings or children be tested?
What it cannot answer aloneWhether plaque is present, what is causing a symptom, or what treatment is right for you.
Pictures of the heart’s arteries
A calcium scan or coronary CT angiogram asks whether plaque is visible in the heart arteries.What it helps answerIs there plaque in my heart’s arteries now?
What it cannot answer aloneWhy plaque developed or what your cholesterol exposure has been across time.
When the extra information may matter
Ask what the result would change.
Current U.S. guidance says ApoB can be useful in selected people when the standard cholesterol panel may not tell the whole story. Research in women has also found that when cholesterol amount and particle number disagree, the particle number can add important risk information.
That does not mean every woman needs every available test. It means ApoB may be worth discussing when the answer could clarify risk or change what happens next.
The answer depends on your full story, not one number in isolation.
Focused expert review of one book section
The review made the explanation stronger.
“Lisa Zahakos reached out to me to review the brief segment of her book that deals with lipids and apoB. I did not know her and I did not agree completely with what she had initially written about apoB. But I was impressed with the rest of what she was writing and the way she is writing it. She sees cardiovascular disease as a process that occurs over time. She focuses on the period of the menopause, but this attention is situated within the continuum of the disease. She writes very well- clearly, concisely- and this reflects the fact she thinks very well.. I would have been honoured to be able to work with her.”Allan D. Sniderman, MD · Edwards Professor of Cardiology and Professor of Medicine, McGill University · Fellow of the Royal Society of Canada
Dr. Sniderman reviewed only a short, defined section of the book on lipids and ApoB. His full statement appears here with written permission to use his name and affiliation. His focused review does not imply endorsement of the full manuscript, this website, its educational checks, or the HEART RESERVE program.
Coming next: Lp(a)
The cholesterol test you may never have had.
Lp(a) is different from ApoB. The 2026 guideline recommends checking it at least once in adulthood. Your level comes mostly from your genes, and it is not included in the usual cholesterol test. The result cannot show whether plaque is present or choose treatment by itself. It can show whether this inherited risk belongs in your heart story.
Lp(a) is largely inherited, so one measurement is often enough. If an earlier result was intermediate, between clearly low and high, ask whether repeating it could change your risk assessment or prevention plan, particularly after menopause. Pregnancy, kidney disease and an underactive thyroid (hypothyroidism) can also affect the result; your clinician can decide whether and when to repeat it. Menopause alone does not mean you need routine repeat testing.
If menopause is part of your story, ask: “I had my Lp(a) checked before. Was it clearly low or high, or was it in an intermediate range? Now that I’m in menopause, should it be repeated?”
2025 ESC/EAS guidance on Lp(a) · 2026 U.S. cholesterol guideline
From Lisa
The most useful medicine is not the longest list of tests. It is knowing which question each test answers—and what could change because you asked it.
That is the standard for every HEART RESERVE Letter: one real question, evidence you can open, clear limits on what the evidence can tell you, and a useful question to discuss with your clinician.
With care,
Lisa Zahakos, RPA-CFounder, HEART RESERVEPut the number into your story
A result is a photograph. Your history is the movie.
Use your private Heart Story to organize the numbers, history, symptoms, and unanswered questions you already have. The tool does not score or diagnose. Your answers stay in this browser tab; save or print a copy before leaving.
Build my Heart StoryEvidence behind this Letter
Sources and review
Sources last checked: September 5, 2026
- 2026 Guideline on the Management of DyslipidemiaACC/AHA Multisociety Guideline · Circulation · 2026
- Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering TherapyJAMA · 2026
- Discordance Between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in WomenClinical Chemistry · 2017
- ApoB and Lp(a): Core Measures to Assess Cardiovascular RiskEuropean Heart Journal · 2025
Independent clinical review is identified only when completed and approved in writing. No external reviewer or organization is implied. Sources do not imply endorsement of HEART RESERVE.